期刊文献+

节拍化疗在癌症患者治疗中的临床应用

下载PDF
导出
摘要 据世界卫生组织(WHO)的报告,2005年统计有760万人死于癌症,估计2015年将达到900万,2030年达到1150万。我国是发展中国家,癌症总体占居民死亡原因的19%,居常见死亡原因的首位;我国现有癌症患者近200余万,在发现的癌症患者中,早期患者为15%~30%,中期患者为40%~55%,晚期患者为50%~70%;肿瘤的平均治愈率只有10%左右,这些不能被治愈的晚期癌症患者理应受到进一步的姑息性治疗和合理的医护照顾。
机构地区 甘肃省肿瘤医院
出处 《甘肃医药》 2010年第2期145-147,共3页 Gansu Medical Journal
  • 相关文献

参考文献15

  • 1俞顺章.世界卫生组织重视癌症斗争的策略[J].中国肿瘤,2009,18(2):88-89. 被引量:4
  • 2孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生社出版.2007.152.
  • 3Kerbel RS, Klement G, Pritchard KL, et a. 1 Continuous lowdose anti - angiogenie./metronomic chemotherapy: from the research laboratory into the oncology clinic[J]. Ann Onco,2002,13(1) : 12 -15.
  • 4Gately S, Kerbel R. Antiangiogenie scheduling of lower dose cancer chemotherapy[J]. Cancer J ,2001,7(5) :427 -436.
  • 5Scharovsky OG, Mainetti LE, Rozados VR. Metronomic chemotherapy: changing the paradigm thatmore is better [ J ]. Current Ontology, 2009, 16(2) : 7 - 15.
  • 6Mancuso P, Colleoni M, Calleri A, et al. Circulating endothelialcellkinetics and viability predictsurvival in breastcancerpatients receivingmetronomic chemotherapy[ J ]. Blood, 2006, 108 (2) :452 - 459.
  • 7Kamat AA, Kim TJ. Landen CN, et el. Metronomic chemotherapy Enhances the efficacy of antivascuhar therapy in ovarian cancer [ J ]. Cancer Res,2007,67( 1 ) :281 -288.
  • 8肖文华.恶性肿瘤的节拍化疗[J].临床肿瘤学杂志,2008,13(12):1139-1142. 被引量:16
  • 9Regazzoni S, Pesce G, Marini G, et al. Low - dose continuous intravenous infusion of 5 -fluorouracil for metastatic breast cancer [ J]. Ann 0nco,1996, 7:807-813.
  • 10Coneale P, Cerretani D, Remondo C, et al. A novelmetronomic chemotherapy regimen ofweekly platinum and daily oral etoposide in high - risk non - small cell lung cancer patients [J].Oncol Rep, 2006, 164:133-140:.

二级参考文献56

  • 1樊晓明,郑发寿,刘红燕,马元华,王振宇.环氧合酶-2特异抑制剂诱导胃癌细胞凋亡的机制研究[J].中华肿瘤杂志,2005,27(3):145-147. 被引量:16
  • 2孙为豪,孙运良,方仁年,欧希龙,薛绮萍,邵耘,许海尘,程蕴琳.环氧化酶-2在胃癌组织中的表达及其与血管生成的关系[J].中华胃肠外科杂志,2005,8(4):343-347. 被引量:18
  • 3刘俊,吕长兴,王家明.同步放化疗治疗不能手术的食管癌临床结果[J].中华放射肿瘤学杂志,2006,15(3):185-187. 被引量:89
  • 4Loven D, Beery E, Yerushalmi R, et al. Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduced VEGF and PDGF-BB levels in rectal carcinoma patients[ J]. Acta Oncol, 2008, 47( 1 ) :104 - 109.
  • 5Garcia AA, Hirte H, Flemin Q, et al. Phase Ⅱ clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase Ⅱ consortia[J]. J Clin Oncol, 2008, 26(1):76 -82.
  • 6Brodowicz T, Krzakowski M,Zwitter M,et al. Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase Ⅲ trial[J]. Lung Cancer, 2006, 52(2) :155 - 163.
  • 7Bottini A, Generali D, Brizzi MP, et al, Randomized phase Ⅱ trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients[J]. J Clin Oncol, 2006, 24(22) :3623 -3628.
  • 8Franchi F, Grassi P, Ferro D, et al. Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer[J]. Eur J Cancer Care(Engl), 2007, 16(3):258-262
  • 9Leong SP, Witte MH. Patterns of metastasis in human solid cancers[ J]. Cancer Treat Res, 2007,135:209 - 221.
  • 10Folkman J. Angiogenesis[ J]. Annu Rev Med, 2006,57 : 1 - 18.

共引文献334

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部